Hematology/Oncology

  • Mark H. Ebell
Chapter

Keywords

Primary Biliary Cirrhosis Training Group Prediction Rule Validation Group Pretest Probability 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979; 15: 1033–1041.PubMedGoogle Scholar
  2. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002–2007.PubMedCrossRefGoogle Scholar
  3. Thorogood J, Bulman AS, Collins T, Ash D. The use of discriminant analysis to guide palliative treatment for lung cancer patients. Clin Oncol 1992; 4: 22–36.CrossRefGoogle Scholar
  4. Schonwetter RS, Robinson BE, Ramirez G. Prognostic factors for survival in terminal lung cancer patients. J Gen Intern Med 1994; 9: 366–371.PubMedCrossRefGoogle Scholar
  5. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980; 65: 25–32.PubMedGoogle Scholar
  6. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879–1886.PubMedCrossRefGoogle Scholar
  7. O’Rourke S, Galea MH, Morgan D, et al. Local recurrence after simple mastectomy. Br J Surg 1994; 81: 386–389.PubMedCrossRefGoogle Scholar
  8. Yamamoto N, Watanabe T, Katsumata N, et al. Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol 1998; 16: 2401–2408.PubMedGoogle Scholar
  9. Aaltomaa S, Lipponen P, Eskelinen M, et al. Predictive value of a morphometric prognostic index in female breast cancer. Oncology 1993; 50: 57–62.PubMedCrossRefGoogle Scholar
  10. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996; 23: 1112–1118.PubMedCrossRefGoogle Scholar
  11. Carmichael JA, Shelley WE, Brown LB, et al. A predictive index of cure versus no cure in advanced ovarian carcinoma patients: replacement of second-look laparotomy as a diagnostic test. Gynecol Oncol 1987; 27: 269–278.PubMedCrossRefGoogle Scholar
  12. Grignani G, Gobbi PG, Formisano R, et al. A prognostic index for multiple myeloma. Br J Cancer 1996; 73: 1101–1107.PubMedCrossRefGoogle Scholar
  13. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10: 316–322.PubMedGoogle Scholar
  14. Margolis DJ, Halpeen AC, Rebbeck T, et al. Validation of a melanoma prognostic model. Arch Dermatol 1998; 134: 1597–1601.PubMedCrossRefGoogle Scholar
  15. Schuchter L, Schultz DJ, Synnestvedt M, et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 1996; 125: 369–375.PubMedGoogle Scholar
  16. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987; 82: 703–713.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Mark H. Ebell
    • 1
  1. 1.Department of Family MedicineMichigan State UniversityEast LansingUSA

Personalised recommendations